These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19443251)

  • 1. [Transfusion of platelet concentrates].
    Bierling P
    Transfus Clin Biol; 2009 May; 16(2):190-4. PubMed ID: 19443251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion-refractory thrombocytopenia during chemotherapy: pathogenesis, frequency and treatment].
    Helleberg C; Taaning EB; Johnsen HE
    Ugeskr Laeger; 1995 Sep; 157(37):5082-6. PubMed ID: 7502374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet transfusion therapy.
    Slichter SJ
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet transfusion: products, indications, dose, threshold and efficacy].
    Andreu G; Vasse J; Tardivel R; Semana G
    Transfus Clin Biol; 2009 May; 16(2):118-33. PubMed ID: 19443257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus and controversies in platelet transfusion.
    Marwaha N; Sharma RR
    Transfus Apher Sci; 2009 Oct; 41(2):127-33. PubMed ID: 19717344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients refractory to platelet transfusion.
    Chockalingam P; Sacher RA
    J Infus Nurs; 2007; 30(4):220-5. PubMed ID: 17667077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
    Stanworth SJ; Hyde C; Brunskill S; Murphy MF
    Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for managing refractoriness to platelet transfusions.
    Dan ME; Schiffer CA
    Curr Hematol Rep; 2003 Mar; 2(2):158-64. PubMed ID: 12901147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Refractoriness to platelet transfusion].
    Tsurumi H; Hara T; Moriwaki H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):332-4. PubMed ID: 9833505
    [No Abstract]   [Full Text] [Related]  

  • 12. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet dosing.
    Schlossberg HR; Herman JH
    Transfus Apher Sci; 2003 Jun; 28(3):221-6. PubMed ID: 12725947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mini-review on platelet refractoriness.
    Rebulla P
    Haematologica; 2005 Feb; 90(2):247-53. PubMed ID: 15710579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion reactions].
    Rebibo D; Simonet M; Hauser L
    Transfus Clin Biol; 2008 Nov; 15(5):289-93. PubMed ID: 18930424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of treatment with platelet concentrates.
    Lanzer G
    Acta Anaesthesiol Scand Suppl; 1996; 109():141-3. PubMed ID: 8901986
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypoplastic thrombocytopenia and platelet transfusion: therapeutic goals.
    Karakatsanis SJ; Papadatos SS; Syrigos KN
    Hosp Pract (1995); 2019 Feb; 47(1):16-23. PubMed ID: 30409035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic platelet transfusions: should they be a treatment of the past?
    Zeller MP; Al-Habsi KS; Heddle NM
    Curr Opin Hematol; 2014 Nov; 21(6):521-7. PubMed ID: 25203535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of refractoriness to platelet transfusion.
    Schiffer CA
    Blood Rev; 2001 Dec; 15(4):175-80. PubMed ID: 11792118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative clinical studies of platelet concentrates: effects on clinical outcome and the use of healthcare resources. NBS Platelet Study Group.
    Pamphilon DH
    Transfus Sci; 1996 Sep; 17(3):343-6. PubMed ID: 10163540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.